A detailed history of Core Cap Advisors, LLC transactions in Vericel Corp stock. As of the latest transaction made, Core Cap Advisors, LLC holds 500 shares of VCEL stock, worth $29,375. This represents 0.0% of its overall portfolio holdings.

Number of Shares
500
Holding current value
$29,375
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$42.25 - $53.56 $21,125 - $26,780
500 New
500 $21,000
Q4 2022

Feb 10, 2023

BUY
$17.65 - $27.37 $335 - $520
19 New
19 $0
Q2 2022

Aug 11, 2022

BUY
$22.88 - $39.45 $434 - $749
19 New
19 $0
Q1 2022

Apr 29, 2022

SELL
$31.69 - $43.29 $602 - $822
-19 Closed
0 $0
Q4 2021

Feb 10, 2022

BUY
$35.2 - $52.6 $668 - $999
19 New
19 $1,000

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.77B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Core Cap Advisors, LLC Portfolio

Follow Core Cap Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Core Cap Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Core Cap Advisors, LLC with notifications on news.